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Abstract - The present study was undertaken to evaluate the anti-inflammatory potential of Murraya koenigii root extracts 
petroleum ether, ethyl acetate and chloroform (Mkpe, MkeA and MkCF, respectively) and Ficus lacor aerial root extracts 
petroleum ether, ethyl acetate, chloroform and ethanol (FLpe, FLeT, FLCF and FLeT, respectively) at doses of 50 and 100 
mg/kg body weight (b.w.) using animal models of acute inflammation (carrageenan-, histamine- and serotonin-induced 
inflammation). The results of the  Murraya koenigii roots chloroform extract caused 66.4% inhibition and the ethanol 
extract of Ficus lacor aerial roots caused 68.3% inhibition at the dose of 50 mg/kg b.w. At a higher dose of 100 mg/kg b.w., 
Mkpe and MkCF showed 55.10% and 70.10% inhibition, respectively. FLpe and FLeT showed 74.50% and 75.40% in-
hibition, respectively, in the carrageenan-induced inflammation model. In histamine-induced inflammation, the MkCF 
showed 60% inhibition, and 67.01% and 68.02% inhibition with the petroleum ether and ethanol extracts, respectively, 
in Ficus lacor aerial roots at the dose of 50 mg/kg b.w. At a higher dose (100 mg/kg b.w.), MkCF showed 64% inhibition. 
FLpe and FLeT showed 70.13%and 74.01% inhibition, respectively; 62.15% and 66.10% inhibition was observed with the 
petroleum ether and ethanol extracts of Ficus lacor aerial roots at 50 mg/kg b.w.  At higher dose (100 mg/kg b.w.), FLpe 
and FLeT showed 69.10% and 68.72% inhibition in serotonin-induced inflammation.
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INTRODUCTION
Inflammation  is  a  complex  biological  process  in-
volving several chemical mediators that are induced 
by the vascular tissue of the body when it comes in 
contact with harmful stimuli such as pollens, irri-
tants, pathogens and damaged cells. The process of 
inflammation involves several events and mediators 
that  are  potent  chemical  substances  found  in  the 
body tissues, such as prostaglandins, leukotrienes, 
prostacyclins,  lymphokines,  and  chemokines  such 
as interferon-α (IFN-α), γ, interleukin (IL)-1, IL-8, 
histamine, 5-hydroxytryptamine (5-hT), and tissue 
necrosis factor-α (Serhan and Savill, 2005).
Anti-inflammatory drugs of synthetic origin are 
classified as steroidal and nonsteroidal anti-inflam-
matory agents. The origin of these chemical com-
pounds started when salicylates were isolated from 
the leaf extract of willow bark (Salix alba) and were 
used by the people of North America in 200 BC; they 
are regarded as the first generation of anti-inflam-
matory  agents  (Rainsford  and  Whitehouse  1980). 
These were followed by the discovery of second- and 
third-generation compounds with preferential and 
selective cyclooxygenase (COX2) inhibitory activi-
ties, such as nimesulide, nabumetone, celecoxib, ro-
fecoxib, valdecoxib and etoricoxib. Apart from the 
nonsteroidal drugs, various corticosteroids such as 1262 RAkeSh k. SINDhU eT AL.
hydrocortisone,  betamethasone,  and  beclometha-
sone are primarily used as anti-inflammatory agents 
(MacLennan et al., 1996; Ang-Lee et al. 2001). 
Some  common  side  effects  of  these  synthetic 
drugs  include  gastric  irritation,  ulceration,  bleed-
ing, renal failure, interstitial nephritis, hepatic fail-
ure,  headache,  thrombocytopenia,  hemolytic  ane-
mia, asthma exacerbation, skin rashes, angioedema 
and pruritis (Anonymous, 1993; Anonymous, 1996). 
hence, the approach for treating inflammatory dis-
eases by herbal drugs has the keen interest of re-
searchers. From a global study, it has been seen that 
the market for herbal drugs in the treatment of in-
flammatory  diseases  constitutes  83%  worldwide 
and is expected to reach a value of over 95% in the 
forthcoming years due to the increased acceptabil-
ity of these preparations (Bent and ko 2004; Boul-
lata and Nace, 2000). According to the WhO, about 
80% of the world’s population relies on traditional 
drugs to treat various types of ailments (Sindhu et al., 
2010). Murraya koenigii Linn (Rutaceae), commonly 
known as Meethi neem, is an aromatic, deciduous 
shrub, found throughout India (pande et al., 2009). 
In traditional medicine, it is used as an antiemetic, 
antidiarrheal, anti-dysentery, febrifuge, blood puri-
fier, tonic, stomachic, flavoring agent in curries and 
chutneys (prajapati et al., 2003). The plant contains 
various types of phytochemicals such as alkaloids, 
flavonoids, amino acids and saponins (Sindhu and 
Arora, 2012). The reported pharmacological activi-
ties are anti-oxidative, cytotoxic (Shah and Juvekar, 
2006), antimicrobial (Manfred et al., 1985), anti-di-
abetic and cholesterol-reducing (kesari et al., 2005) 
and antiulcer (Xie et al., 2006), with positive ino-
tropic effect (Rahman and Gray, 2005). Ficus lacor 
Buch. -ham is a synonym of Ficus infectoria Roxb. It 
is locally known as pilkhan, and it is a large decidu-
ous, rapidly growing closely foliaceous tree about 20 
m in height with a fine shaped crown. It is widely 
distributed in tropical and subtropical regions of the 
world. It also grown in various humid regions in In-
dia (Chopra et al., 1956). The bark of the plant in the 
traditional medicine of India is used for the treat-
ment of ulcers, for expelling roundworms and for the 
treatment of leucorrhoea. The leaves are also used for 
treating various skin problems (Gamble, 1922; Nad-
karni and Nadkarni, 1976). phytochemical screen-
ing of the plant revealed the presence of terpenoids, 
sterol,  amino  acids  and  flavonoids,  etc.  Medicinal 
plants or isolated bioactive constituents form one of 
the major sources of raw materials for drugs (Balgia, 
2003) in preventive or curative applications (Jain and 
Yadav, 1994). The present study was undertaken to 
evaluate the anti-inflammatory potential of Murraya 
koenigii root extracts and aerial root extracts of Ficus 
lacor.
MATeRIALS AND MeThODS
Murraya koenigii roots were collected Jhansla village, 
patiala (punjab) and aerial roots of Ficus lacor were 
collected during the month of the July 2009 from 
panchkula (haryana), North India. The plant mate-
rial was taxonomically identified and authenticated 
by  Dr.  h.B.  Singh,  head,  Raw  Materials  herbari-
um and Museum Division, with ref. no. NISCAIR/
RhMD/Consult/2010-11/1638/236.  The  voucher 
specimen has been deposited in the herbarium sec-
tion of the phytochemistry and pharmacognosy Di-
vision, Chitkara College of pharmacy, Chitkara Uni-
versity, punjab.
Preparation of extracts
The powdered material was subjected to successive 
hot  extraction  (Soxhlet)  with  different  solvents  in 
increasing order of polarity from petroleum ether 
(pe), ethyl acetate (eA), chloroform (CF) and etha-
nol (eT), followed by distillation and concentration 
in a water bath (Mukherjee, 2003).
Phytochemical screening
The  phytochemical  screening  of  different  extracts 
using various chemical and reagents was carried out 
following the method of harbone (1973)
Experimental animals
Wistar rats of either sex (weighing 160-200 g) were 
used as per experimental protocols (IAeC/CCp/12/ANTI-INFLAMMATORY pOTeNTIAL OF DIFFeReNT eXTRACTS ISOLATeD FROM The ROOTS OF FiCUS lACor BUCh 1263
pR-005) after approval from the Institutional Animal 
ethical Committee, Chitkara College of pharmacy, 
Chitkara University, Jhansla, Rajpura. The animals 
were housed under standard environmental condi-
tions (25±2°C and relative humidity 50±5%) and fed 
with standard diet and water ad libitum. The animals 
were deprived of food for 24 h before experimenta-
tion but allowed free access to tap water throughout. 
each group comprised 6 rats. 
Toxicity studies
Acute toxicity study was performed for ethanol ex-
tract of both plants according to the acute toxic classic 
method as per OeCD guidelines (Anonymous, 2000). 
Albino rats were used for acute toxicity study. The ani-
mals were fasted overnight providing only water, after 
which the extract was administered orally at the dose 
of 100 mg/kg. The rats were observed for 14 days. If 
mortality occurred in two out of three animals, then 
the dose administered was considered toxic. If mor-
tality was observed in one animal, then the same dose 
was repeated to confirm the toxic dose. If mortality 
was not observed, the procedure was repeated for 
further higher doses – 50, 200 and 2 000 mg/kg b.w. 
The animals were observed for toxic symptoms such 
as behavioral changes, changes in locomotor func-
tions, convulsions and mortality for 72 h.
Dose
Indomethacin  (2.5mg/kg  b.w.)  and  pyrilamine  (1 
mg/kg b.w.) were selected as a standard for anti-in-
flammatory activity. The doses of different extracts 
were 50 and 100 mg/kg b.w. The stock solution of 
standard was prepared in DMSO.
phARMACOLOGICAL SCReeNING
inhibition of carrageenan-induced paw edema in rats
Control group I was given normal saline 1 h before 
the carrageenan injection. experimental groups were 
given doses of various extracts or fractions in 0.5ml 
of normal saline, injected intraperitoneally and orally 
1 h before injection of 0.1 ml of 1% carrageenan solu-
tion in the right hind paw under the plantar aponeu-
rosis (s.c) for induction of edema. The volume of paw 
edema was determined by plethysmometer, a dose 
response relationship was established for both oral 
and i.p. dose and a correlation was established be-
tween i.p. and oral doses producing maximum anti-
inflammatory effect. The reference group was given 
Indomethacin 2.5 mg/kg 1h before the carrageenan 
injection.  percentage  inhibition  of  edema  relative 
to the control group was calculated as described by 
Winter et al. (1962)
inhibition of histamine and serotonin induced paw 
edema in rats
In another set of experiments, serotonin and hista-
mine (0.1 ml of 1mg/ml of both) were used as phlo-
gistic agents. The various extracts, standard pyril-
amine and control vehicle (solution of 2.5% DMSO 
and 2.5% Tween 20) were administered intraperito-
neally 1 h before the injection of the inflammatory 
mediators in their respective groups. Different doses 
of extract or fractions were injected intraperitoneally 
with vehicle to establish the dose response relation-
ship; 0.1ml serotonin (1mg/ml) or histamine (1mg/
ml) was injected and response noted at 30 min and 
60 min, respectively. pyrilamine maleate (1 mg/kg) 
was used as the antagonist (reference) of histamine 
and as a standard drug in the reference group. The 
volume of paw edema was determined by plethys-
mometer (Singh et al., 1996). 
Statistical analysis
Data  obtained  from  animal  experiments  were  ex-
pressed as mean standard error (±S.e.M.). Statistical 
differences between the treatments and the control 
were evaluated by ANOVA and Students-Newman-
keuls  post  hoc  tests.  Significance  of  data  was  ex-
pressed as *p < 0.05; **p < 0.01; and ***p < 0.001.
ReSULTS AND DISCUSSION
The results of the preliminary phytochemical screen-
ing of various extracts of Ficus lacor plants revealed 
the presence of phytoconstituents such as glycosides, 1264 RAkeSh k. SINDhU eT AL.
alkaloids, phenolic and tannins, flavonoids, and Mur-
raya koenigii showed the presence of alkaloids, flavo-
noids, carbohydrates, sterol and amino acids in vari-
ous extracts. The ethanol extract of both plants did 
not produce any toxic effects or symptoms in rats. 
Therefore,  these  extracts  were  considered  safe  for 
further pharmacological investigation. The anti-in-
flammatory potential of the various extracts of Ficus 
lacor aerial roots and Murraya koenigii roots against 
acute pedal edema is shown in Tables 1-6, and show 
significant anti-inflammatory activity comparable to 
standard drugs. 
Table 1. Inhibition of Carragenan induced edema (paw volume) in rats by various fractions from Murraya koenigii and Ficus lacor  
groups  Isolated Fractions  Dose mg/kg i.p. M.E.V and SEM  P.I. (% Inhibition) 
I  Normal 
(Normal saline) Arthritic 
control 
0.37±0.02  -- 
II.  Mkpe  50  0.26± 0.056  32.43 
III.  MkeA  50  0.24± 0.049*  36.8 
IV.  MkCF  50  0.14± 0.051 *** 66.4 
V.  FLpe  50  0.21± 0.058 ** 41.9 
VI.  FLeA  50  0.26±0.048  30.7 
VII.  FLCF  50  0.25± 0.058* 35.9 
VIII.  FLeT  50  0.12±0.049 *** 68.3 
IX.  Indomethacin  2.5 mg  0.09±0.057 *** 81.6 
Table 2. Inhibition of Carragenan induced edema (paw volume) in rats by various fractions from Murraya koenigii and Ficus lacor  
groups  Isolated Fractions  Dose mg/kg i.p.  M.E.V and SEM 
P.I. (% Inhibi-
tion) 
I  Normal 
(Normal saline) Arthritic 
control 
0.37±0.02  -- 
II.  Mkpe  100  0.20±0.058 ** 55.10 
III.  MkeA  100  0.22± 0.050 * 38.80
IV.  MkCF  100  0.10±0.050 *** 70.10 
V.  FLpe  100  0.09±0.040 *** 74.50 
VI.  FLeA  100  0.26±0.048  30.70 
VII.  FLCF  100  0.21± 0.058 * 41.90 
VIII.  FLeT  100  0.10±0.037 *** 75.40 
IX.  Indomethacin  2.5 mg  0.08±0.057  80.80 
MeV Values represent Mean± SeM; MeV = Mean edema volume & pI = percentage inhibition; Group I- edema Control (saline); 
Group II- Arthritic rats treated with  from Mkpe fraction,  Group III- Arthritic rats treated with MkeA fraction, Group IV- Arthritic 
rats treated MkCF fraction from M. koenigii, Group V - Arthritic rats treated with FLpe fraction, Group VI- Arthritic rats treated with 
FLeA fraction,   Group VII- Arthritic rats treated with FLCF fraction, Group VIII- Arthritic rats treated with FLeT fraction from Ficus 
lacor, Group IX- Arthritic rats treated with Indomethacin 2.5mg/kg. *p<0.05, **p<0.01, *** p <0.001 as compared to arthritic control.ANTI-INFLAMMATORY pOTeNTIAL OF DIFFeReNT eXTRACTS ISOLATeD FROM The ROOTS OF FiCUS lACor BUCh 1265
Carrageenan-induced paw edema in rats
The  Murraya  koenigii  roots  chloroform  extract 
showed 66.4% inhibition and 68.3% inhibition was 
shown in the ethanol extract of Ficus lacor aerial roots 
at the dose of 50mg/kg b.w. as shown in Table 1 and 
figure 1(A and B) . At higher dose (100 mg/kg b.w.), 
Murraya  koenigii  root  extracts  Mkpe  and  MkCF 
showed 55.10% and 70.10% inhibition, respectively. 
Ficus lacor extracts FLpe and FLeT showed 74.50% 
and 75.40% inhibition, respectively, as shown in Ta-
ble 2 and figure 1 (C and D).
 Histamine-induced paw edema in rats
The  Murraya  koenigii  roots’  chloroform  extract 
showed 60% inhibition, and 67.01% 68.02% inhibi-
tion was shown in the petroleum ether and ethanol 
extract of Ficus lacor aerial roots, respectively, at the 
dose of 50mg/kg b.w. as shown in Table 3 and figure 
2 (A and B). At higher dose (100 mg/kg b.w.), Mur-
raya koenigii roots’ extracts MkCF showed 64% in-
hibition. Ficus lacor extracts FLpe and FLeT showed 
70.13% and 74.01% inhibition, respectively, as shown 
in Table 4 and figure 2 (C and D).
 
Fig. 1 Inhibition of Carrageenan induced edema (paw volume) in rats by different extracts from Murraya koenigii and Ficus lacor, A and 
B Shows at lower dose and C and D at higher doses.1266 RAkeSh k. SINDhU eT AL.
Table 3. Inhibition of histamine induced paw edema in rats by various fractions from Murraya koenigii and Ficus lacor 
group 
Isolated Frac-
tions 
Dose mg/kg  Histamine 
MEV  PI 
I.  Normal
(Normal saline)  
Arthritic control 
0.37±0.02  -- 
II.  Mkpe  50  0.42±0.04  13.66 
III.  MkeA  50  0.27±0.10  24.10 
IV.  MkCF  50 
0.15±0.06**
60.00
V.  FLpe  50.  0.10±0.04***  67.01 
VI.  FLeA  50    0.22±0.04 **  43.46 
VII.  FLCF  50  0.24±0.01  38.66 
VIII.  FLeT  50.  0.12±0.04***  68.02 
IX  pyrilamine  1mg/kg  0.08±0.04**  79.01 
Table 4. Inhibition of histamine induced paw edema in rats by various fractions from Murraya koenigii and Ficus lacor 
group 
Isolated Fractions  Dose mg/kg 
Histamine 
MEV  PI 
I.  Normal
(Normal saline) Arthritic 
control 
0.37±0.02  --
II.  Mkpe  100   0.23±0.04*  25.1 
III.  MkeA  100  0.22±0.10  35.66 
IV.  MkCF  100   0.13±0.04** 64.00
V.  FLpe  100  0.10±0.04***  70.13 
VI.  FLeA  100  0.21±0.04 **  41.66 
VII.  FLCF  100  0.25±0.01  38.66 
VIII.  FLeT  100.  0.9±0.04***  74.01 
IX  pyrilamine  1mg/kg  0.06±0.04**  82.01
MeV Values represent Mean± SeM; MeV = Mean edema volume & pI = percentage inhibition; Group I- edema Control (saline); 
Group II- Arthritic rats treated with  Mkpe fraction,  Group III- Arthritic rats treated with MkeA fraction, Group IV- Arthritic rats 
treated MkCF fraction from M. koenigii, Group V - Arthritic rats treated with FLpe fraction, Group VI- Arthritic rats treated with 
FLeA fraction,   Group VII- Arthritic rats treated with FLCF fraction, Group VIII- Arthritic rats treated with FLeT fraction from Ficus 
lacor, Group IX- Arthritic rats treated with pyrilamine 1mg/kg. *p<0.05, **p<0.01, *** p <0.001 as compared to arthritic controlANTI-INFLAMMATORY pOTeNTIAL OF DIFFeReNT eXTRACTS ISOLATeD FROM The ROOTS OF FiCUS lACor BUCh 1267
Serotonin-induced paw edema in rats
The  62.15%  and  66.10%  inhibition  in  petroleum 
ether and ethanol extracts of Ficus lacor aerial roots 
at the dose of 50mg/kg b.w. are shown in Table 5 and 
figure 3 (A and B). At higher dose (100 mg/kg b.w.), 
Ficus lacor extracts FLpe and FLeT showed 69.10 
and 68.72% inhibition, respectively, as shown in Ta-
ble 6 and figure 3 (C and D).
From  these  results,  it  can  be  concluded  that 
Mkpe, MkCF, FLpe and FLeT at the dose of 100 
mg/kg b.w. showed significant anti-inflammatory ac-
tivity due to presence of phytoconstituents.
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Fig. 2 Inhibition of histamine induced paw edema in rats by different extracts from Murraya koenigii and Ficus lacor, A and B Shows at 
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